Author's posts
Mississippi hospital interim CEO eyes Medicaid lifeline
In a bid to overcome continued financial setbacks, Greenwood (Miss.) Leflore Hospital could begin receiving over $10 million in extra Medicaid supplement payments annually, the hospital’s interim CEO, Gary Marchand, told Becker’s.
LinkedIn to add new features for nurses
LinkedIn has added several new features to support nurses with job searches and networking.
CVS sues U.S. over $400M in denied tax deductions
CVS Health is suing the United States, alleging the government owes it more than $400 million in tax deductions.
St. Mary's Health Care System taps former HCA exec as chief medical officer
St. Mary’s Health Care System in Athens, Ga., has named Eric Schuck, MD, chief medical officer.
Hospitals, health systems undergoing rebrands in 2023
In highly competitive healthcare markets, hospitals and health systems are rebranding to differentiate themselves and stand out from competitors.
CDC probes cluster of ocular syphilis cases
A CDC investigation into a cluster of rare, ocular syphilis cases that cropped up in southwestern Michigan between March and July 2022 found that the incidents may be linked by an unidentified strain of Treponema pallidum — the bacterium that causes sy…
Kansas hospital ramps up staffing in wake of Ardent ransomware attack
In response to the ransomware attack on Nashville, Tenn.-based Ardent Health Services and its affiliates, Stormont Vail Health took action by augmenting staffing levels at its hospital, emergency department and Express Care clinics, the Topeka Capital-…
California hospital IT network breached
Mission Community Hospital in Los Angeles is notifying patients that an unauthorized party gained access to its IT network in May, compromising patient information.
California hospital up for $105M bond approval
Watsonville (Calif.) Community Hospital could be on the upcoming March 5 primary ballot for a $105 million bond measure approval, the Santa Cruz Sentinel reported Nov. 27.
FDA approves 1st drug for aggressive, noncancerous tumors
The FDA approved Ogsiveo (nirogacestat), the first drug indicated for locally aggressive, noncancerous tumors, on Nov. 27.
